Benzinga | Nov 2, 2020 07:17AM EST

Apellis Pharmaceuticals Q3 EPS $(1.79) Down From $(1.09) YoY, Sales $646.00K

Apellis Pharmaceuticals (NASDAQ:APLS) reported quarterly losses of $(1.79) per share. This is a 64.22 percent decrease over losses of $(1.09) per share from the same period last year. The company reported $646.00 thousand in sales this quarter.